Feature | Coronavirus (COVID-19) | August 22, 2022

Anthony Fauci, MD, Announces He is Stepping Down

NIH Image Gallery from Bethesda, Maryland, USA, Public domain, via Wikimedia Commons

NIH Image Gallery from Bethesda, Maryland, USA, Public domain, via Wikimedia Commons


Anthony S. Fauci, MD, who was instrumental in leading the country through the COVID-19 pandemic, announced today through a statement from the National Institutes of Health (NIH) that he is stepping down from the positions of Director of the National Institute of Allergy and Infections Diseases (NIAID) and Chief of the NIAID Laboratory of Immunoregulation, as well as the position of Chief Medical Advisor to President Joe Biden, effective in December of this year to pursue the next chapter of his career. 

Fauci stated in the release:

"It has been the honor of a lifetime to have led the NIAID, an extraordinary institution, for so many years and through so many scientific and public health challenges. I am very proud of our many accomplishments. I have worked with — and learned from — countless talented and dedicated people in my own laboratory, at NIAID, at NIH and beyond. To them I express my abiding respect and gratitude.

"Over the past 38 years as NIAID Director, I have had the enormous privilege of serving under and advising seven Presidents of the United States, beginning with President Ronald Reagan, on newly emerging and re-emerging infectious disease threats including HIV/AIDS, West Nile virus, the anthrax attacks, pandemic influenza, various bird influenza threats, Ebola and Zika, among others, and, of course, most recently the COVID-19 pandemic. I am particularly proud to have served as the Chief Medical Advisor to President Joe Biden since the very first day of his administration.

"While I am moving on from my current positions, I am not retiring. After more than 50 years of government service, I plan to pursue the next phase of my career while I still have so much energy and passion for my field. I want to use what I have learned as NIAID Director to continue to advance science and public health and to inspire and mentor the next generation of scientific leaders as they help prepare the world to face future infectious disease threats.

"Over the coming months, I will continue to put my full effort, passion and commitment into my current responsibilities, as well as help prepare the Institute for a leadership transition. NIH is served by some of the most talented scientists in the world, and I have no doubt that I am leaving this work in very capable hands.

"Thanks to the power of science and investments in research and innovation, the world has been able to fight deadly diseases and help save lives around the globe. I am proud to have been part of this important work and look forward to helping to continue to do so in the future."

For more information: www.nih.gov

Related Long-COVID Content:  

MRI Sheds Light on COVID Vaccine-Associated Heart Muscle Injury  

What We Know About Cardiac Long-COVID Two Years Into the Pandemic   

VIDEO: Long-term Cardiac Impacts of COVID-19 Two Years Into The Pandemic — Interview with Aaron Baggish, M.D.  

VIDEO: Long-COVID Presentations in Cardiology at Beaumont Hospital — Interview with Justin Trivax, M.D.  

VIDEO: Cardiac Presentations in COVID Long-haulers at Cedars-Sinai Hospital — Interview with Siddharth Singh, M.D.  

Find more COVID news and videos  

Related COVID Content:  

COVID-19 Fallout May Lead to More Cancer Deaths  

Kawasaki-like Inflammatory Disease Affects Children With COVID-19  

FDA Adds Myocarditis Warning to COVID mRNA Vaccine Clinician Fact Sheets  

CMS Now Requires COVID-19 Vaccinations for Healthcare Workers by January 4  

Cardiac MRI of Myocarditis After COVID-19 Vaccination in Adolescents  

Small Number of Patients Have Myocarditis-like Illness After COVID-19 Vaccination  

Overview of Myocarditis Cases Caused by the COVID-19 Vaccine  

Case Study Describes One of the First U.S. Cases of MIS-C  

NIH-funded Project Wants to Identify Children at Risk for MIS-C From COVID-19  


Related Content

News | Coronavirus (COVID-19)

November 25, 2022 — A large study found that myocarditis after SARS-CoV-2 vaccination was rare but higher in younger ...

Home November 25, 2022
Home
News | Coronavirus (COVID-19)

November 10, 2022 — Researchers at the University of Maryland School of Medicine’s (UMSOM) Center for Precision Disease ...

Home November 10, 2022
Home
News | Coronavirus (COVID-19)

November 3, 2022 — In the past several years, myocarditis has been of public interest because of cases associated with ...

Home November 03, 2022
Home
News | Coronavirus (COVID-19)

November 2, 2022 — A comprehensive review and meta-analysis of published research confirm that young adults (40 years ...

Home November 02, 2022
Home
News | Coronavirus (COVID-19)

October 27, 2022 — New data analysis from the Smidt Heart Institute at Cedars-Sinai found that deaths from heart attacks ...

Home October 27, 2022
Home
News | Coronavirus (COVID-19)

October 17, 2022 — A national study suggests that risk factors for cardiovascular disease, such as age, smoking and ...

Home October 17, 2022
Home
News | Coronavirus (COVID-19)

September 26, 2022 — Kawasaki disease (KD) is the leading cause of acquired heart disease in children in developed ...

Home September 26, 2022
Home
News | Coronavirus (COVID-19)

September 7, 2022 — A new paper in European Heart Journal - Digital Health, published by Oxford University Press ...

Home September 07, 2022
Home
News | Coronavirus (COVID-19)

August 26, 2022 — COVID mRNA vaccines are associated with a decreased risk of death in patients with heart failure ...

Home August 26, 2022
Home
News | Coronavirus (COVID-19)

August 23, 2022 — In a detailed analysis of nearly 43 million people, ages 13 and older, who received at least one dose ...

Home August 23, 2022
Home
Subscribe Now